| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +134,648 | 69% | $2.26 | +$304,835 |
| Sells | 1 | -61,194 | 31% | $1.62 | -$99,331 |
| Net | +3 | +73,454 | 38% | +$205,505 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Marvin Slosman | CEO and President, Director | $5,858,495 | +$24,999 | +0.43% | 14 Jan 2026 |
| Craig Shore | CFO and CAO | $2,226,709 | 07 Jan 2025 | ||
| Shane Thomas Gleason | Chief Commercial Officer | $1,827,239 | -$99,331 | -5.2% | 15 Jan 2026 |
| Andrea Tommasoli | Chief Operating Officer | $1,698,812 | 14 Jan 2026 | ||
| GARY S. ROUBIN | Director | $1,325,170 | +$99,999 | +8.2% | 14 Jan 2026 |
| Michael Lawless | Chief Financial Officer | $1,231,217 | 14 Jan 2026 | ||
| Thomas J. Kester | Director | $1,105,160 | +$74,998 | +7.3% | 15 Sep 2025 |
| MICHAEL BERMAN | Director | $1,063,692 | 14 Jan 2026 | ||
| Paul Stuka | Director | $708,846 | +$104,839 | +17% | 14 Jan 2026 |
| Kathryn Arnold | Director | $584,957 | 30 Dec 2025 | ||
| Patrick Verta | EVP Clinical/Medical Affairs | $578,187 | 07 Jan 2025 | ||
| Scott R. Ward | Director | $263,165 | 14 Jan 2026 | ||
| Danny L. Dearen | Director | $181,643 | 14 Jan 2026 | ||
| RAYMOND W. COHEN | Director | $164,502 | 14 Jan 2026 | ||
| Campbell Rogers | Director | $70,761 | 13 Oct 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|